Eric Ende
Chairman bei MATINAS BIOPHARMA HOLDINGS, INC.
Vermögen: 5 Mio $ am 31.03.2024
Profil
Eric J.
Ende is the founder of Wellfit Holdings LLC.
He currently holds the position of Chairman at Matinas BioPharma Holdings, Inc. and Director at Matinas BioPharma, Inc. He is also a Director at Mesa Therapeutics, Inc. and an Independent Director at Avadel Pharmaceuticals Plc.
In addition, he is the President of Ende Consulting Group, Inc. and Ende Biomedical Consulting Group, Inc. His former positions include being a Director at Amylin Pharmaceuticals, Inc., Progenics Pharmaceuticals, Inc., Genzyme Corp., and NeuBase Therapeutics, Inc. He also worked as a Research Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. Dr. Ende obtained his undergraduate degree from Emory University in 1990.
He holds an MBA from New York University and The Leonard N Stern School of Business, both conferred in 1997.
He also earned a doctorate from the Icahn School of Medicine at Mount Sinai in 1994.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
18.05.2023 | 167 900 ( 0,09% ) | 3 Mio $ | 31.03.2024 | |
01.08.2023 | 154 900 ( 0,09% ) | 3 Mio $ | 31.03.2024 | |
18.03.2024 | 144 092 ( 0,07% ) | 39 049 $ | 31.03.2024 |
Aktive Positionen von Eric Ende
Unternehmen | Position | Beginn |
---|---|---|
MATINAS BIOPHARMA HOLDINGS, INC. | Chairman | 01.10.2022 |
AVADEL PHARMACEUTICALS PLC | Director/Board Member | 01.12.2018 |
Ende Consulting Group, Inc. | President | 07.03.2011 |
Mesa Therapeutics, Inc. | Director/Board Member | - |
Wellfit Holdings LLC
Wellfit Holdings LLC Information Technology ServicesTechnology Services Wellfit Holdings LLC provides computer programming services. The private company is based in Palm Beach Gardens, FL. The company was founded by Eric J. Ende. Eric J. Ende has been the CEO since incorporation. | Chief Executive Officer | - |
Ende Biomedical Consulting Group, Inc.
Ende Biomedical Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Ende Biomedical Consulting Group, Inc. provides biomedical consulting services. The private company is based in Palm Beach Gardens. | President | 01.01.2009 |
Matinas BioPharma, Inc. | Director/Board Member | 01.05.2017 |
Ehemalige bekannte Positionen von Eric Ende
Unternehmen | Position | Ende |
---|---|---|
NEUBASE THERAPEUTICS, INC. | Director/Board Member | 12.05.2023 |
PROGENICS PHARMACEUTICALS, INC. | Director/Board Member | 19.06.2020 |
░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ausbildung von Eric Ende
Emory University | Undergraduate Degree |
New York University | Masters Business Admin |
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
AVADEL PHARMACEUTICALS PLC | Health Technology |
NEUBASE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 9 |
---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch, Pierce, Fenner & Smith, Inc. (MLPFS) is the SEC-registered broker/dealer subsidiary of Merrill Lynch & Co., Inc., ultimately held by Charlotte-based Bank of America Corp. (NYSE: BAC). The firm was founded in 1958 and is headquartered in New York City. In 2010, Banc of America Securities LLC merged with MLPFS and the firm uses the trade name Bank of America Merrill Lynch. MLPFS's global strategy and economics team serves institutional and individual investors using a wide range of macroeconomic disciplines. Their analysis of global issues provides clients with investment ideas, market forecasts, macro overviews and specific sector recommendations across asset classes, regions and disciplines. Their equity research team conducts fundamental analysis on companies globally and provides institutional and retail clients with industry-specific and in-depth research and analysis on numerous industries. The firm's global fixed-income and equity-linked research focuses on fixed-income and equity derivatives, fixed-income strategy, convertibles, commodities, high-yield, mortgages, municipals and global foreign exchange. | Finance |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Matinas BioPharma, Inc. | |
Mesa Therapeutics, Inc. | |
Wellfit Holdings LLC
Wellfit Holdings LLC Information Technology ServicesTechnology Services Wellfit Holdings LLC provides computer programming services. The private company is based in Palm Beach Gardens, FL. The company was founded by Eric J. Ende. Eric J. Ende has been the CEO since incorporation. | Technology Services |
Ende Biomedical Consulting Group, Inc.
Ende Biomedical Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Ende Biomedical Consulting Group, Inc. provides biomedical consulting services. The private company is based in Palm Beach Gardens. | Commercial Services |
Ende Consulting Group, Inc. |